ORPEA: Downwards Thresholds Crossing by CPPIB

Rhea-AI Summary

ORPEA S.A., a leading global player in frailty care, has reported that the Canadian Pension Plan Investment Board (CPPIB) has reduced its holdings in the company. Following the sale of 7,424,188 shares between February 2 and February 7, 2023, CPPIB has now crossed below the legal thresholds of 20%, 15%, 10%, and 5% of the Company’s voting rights and share capital. CPPIB now holds 1,950,000 ORPEA shares, which equates to 3.01% of the share capital and 5.02% of the voting rights. ORPEA operates across 22 countries with over 72,000 employees, serving more than 255,000 patients and residents annually.

Positive

• The Canadian Pension Plan Investment Board (CPPIB) has reduced its shareholding, potentially indicating improved market sentiment.
• ORPEA operates in 22 countries, showcasing a diversified global presence.

Negative

• CPPIB's decrease in holdings from 14.50% to 3.01% may indicate loss of institutional confidence.
• The significant sale of shares might lead to downward pressure on ORPEA's stock price.

PUTEAUX, France--(BUSINESS WIRE)-- Regulatory News:

ORPEA S.A. (Paris:ORP) (the "Company") has been notified that the Canadian Pension Plan Investment Board ("CPPIB") has crossed downwards the legal thresholds of (i) 20% and 15% of the voting rights, (ii) 10% of the share capital and voting rights and (iii) 5% of the share capital of the Company, following the sale on the market by CPPIB of 7,424,188 ORPEA shares, between 2 February and 7 February 2023.

Following this sale, CPPIB (which held 14.50% of the share capital and 24.16% of the voting rights of the Company) holds 1,950,000 ORPEA shares, representing 3.01% of the share capital and 5.02% of the voting rights of the Company.

About ORPEA

ORPEA is a leading global player, expert in the care of all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living, home care), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 72,000 employees and welcomes more than 255,000 patients and residents each year.

https://www.orpea-group.com/en/

ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230208006010/en/

Investor Relations

ORPEA

Jean-Baptiste Roussille

Head of Investor Relations

j-b.roussille@orpea.net

Benoit Lesieur

Investor Relations Director

b.lesieur@orpea.net

Toll free tel. nb. for shareholders:

+33 (0) 805 480 480

Investor Relations

NewCap

Dusan Oresansky

Tel.: +33 (0)1 44 71 94 94

ORPEA@newcap.eu

Media Relations

ORPEA

Isabelle Herrier-Naufle

Media Relations Director

Tel.: +33 (0)7 70 29 53 74

i.herrier-naufle@orpea.net

Image 7

Charlotte Le Barbier

Tel.: +33 (0)6 78 37 27 60

clebarbier@image7.fr

Source: ORPEA S.A.

FAQ

What recent change occurred with ORPEA's stock held by CPPIB?

CPPIB has decreased its shareholding in ORPEA, dropping below key legal thresholds.

How many shares did CPPIB sell of ORPEA?

CPPIB sold 7,424,188 shares of ORPEA between February 2 and February 7, 2023.

What is CPPIB's current ownership percentage in ORPEA after the sale?

CPPIB currently holds 1,950,000 shares, representing 3.01% of ORPEA's share capital.

How does CPPIB's reduction in holdings affect ORPEA's stock?

The reduction may lead to lower investor confidence and could put downward pressure on ORPEA's stock price.